Burcon Nutrascience Corporation
BU.TO
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 79.40% | -20.92% | 51.51% | -50.16% | -59.19% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 79.40% | -20.92% | 51.51% | -50.16% | -59.19% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -268.27% | -127.24% | -24.22% | -50.16% | -83.33% |
| SG&A Expenses | 15.04% | 12.68% | 2.96% | -6.86% | -23.62% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.80% | 10.37% | -2.20% | -10.66% | -27.11% |
| Operating Income | -7.94% | -11.96% | 4.24% | 8.75% | 25.54% |
| Income Before Tax | -10.75% | 61.14% | 68.11% | 70.67% | 74.34% |
| Income Tax Expenses | -36.08% | -36.08% | -36.08% | -36.08% | -99.06% |
| Earnings from Continuing Operations | -10.55% | 61.40% | 68.36% | 70.91% | 74.52% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.55% | 61.40% | 68.36% | 70.91% | 74.52% |
| EBIT | -7.94% | -11.96% | 4.24% | 8.75% | 25.54% |
| EBITDA | -6.94% | -11.57% | 5.01% | 9.52% | 26.22% |
| EPS Basic | 6.55% | 67.92% | 72.85% | 73.87% | 76.23% |
| Normalized Basic EPS | -153.85% | 24.80% | 43.35% | 50.62% | 88.00% |
| EPS Diluted | 6.55% | 67.92% | 72.85% | 73.87% | 76.23% |
| Normalized Diluted EPS | -153.85% | 24.80% | 43.35% | 50.62% | 88.00% |
| Average Basic Shares Outstanding | 18.16% | 16.92% | 15.71% | 11.64% | 7.63% |
| Average Diluted Shares Outstanding | 18.16% | 16.92% | 15.71% | 11.64% | 7.63% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
